Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-12-26 Purchase | 2023-12-28 4:39 pm | Edgewise Therapeutics Inc. | EWTX | Fox Jonathan C Director | 10,857 | $9.2989 | $100,958 | 10,857 (Direct) | View |
2020-09-17 Sale | 2020-09-18 4:06 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 5,767 | $50.16 | $289,259 | 380,967 (Indirect Direct) | View |
2020-09-14 Sale | 2020-09-16 6:35 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 4,233 | $50.14 | $212,224 | 386,734 (Indirect Direct) | View |
2020-07-07 Sale | 2020-07-09 4:05 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 5,000 | $50 | $250,000 | 390,967 (Indirect Direct) | View |
2020-06-03 Sale | 2020-06-05 4:06 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 5,000 | $50 | $250,000 | 394,879 (Indirect Direct) | View |
2020-05-28 Sale | 2020-06-01 4:05 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 5,000 | $50 | $250,000 | 401,475 (Indirect Direct) | View |
2020-04-23 Sale | 2020-04-27 4:05 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 5,000 | $50 | $250,000 | 406,475 (Indirect Direct) | View |
2020-03-02 Sale | 2020-03-04 4:05 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 10,000 | $51.57 | $515,706 | 411,475 (Indirect Direct) | View |
2020-02-13 Sale | 2020-02-19 06:05 am | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 10,000 | $54 | $540,000 | 421,475 (Indirect Direct) | View |
2020-01-14 Sale | 2020-01-16 6:35 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 10,000 | $55.01 | $550,072 | 433,107 (Indirect Direct) | View |
2019-12-04 Sale | 2019-12-05 7:31 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 10,000 | $58.9 | $589,048 | 443,377 (Indirect Direct) | View |
2019-11-25 Sale | 2019-11-27 9:00 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 10,000 | $56.52 | $565,218 | 454,377 (Indirect Direct) | View |
2019-11-21 Sale | 2019-11-22 9:00 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 10,000 | $55.11 | $551,073 | 464,377 (Indirect Direct) | View |
2019-11-15 Sale | 2019-11-19 4:05 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 15,000 | $48.65 | $729,703 | 474,377 (Indirect Direct) | View |
2019-10-15 Sale | 2019-10-16 4:58 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 5,000 | $36.16 | $180,818 | 489,377 (Indirect Direct) | View |
2019-09-16 Sale | 2019-09-18 4:05 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 5,000 | $45.74 | $228,722 | 494,377 (Indirect Direct) | View |
2019-08-15 Sale | 2019-08-19 7:18 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 5,000 | $38.72 | $193,596 | 499,377 (Indirect Direct) | View |
2019-07-15 Sale | 2019-07-17 4:05 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 15,000 | $40.04 | $600,561 | 504,377 (Indirect Direct) | View |
2019-05-30 Sale | 2019-05-31 4:17 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 5,000 | $32.64 | $163,179 | 516,527 (Indirect) | View |
2019-05-03 Sale | 2019-05-06 8:37 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 5,000 | $25.03 | $125,150 | 521,527 (Indirect) | View |
2019-05-01 Sale | 2019-05-03 9:52 pm | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 5,000 | $25.46 | $127,287 | 527,608 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-06-12 Option Award | 2023-06-14 7:30 pm | 2024-06-12 2033-06-12 | Edgewise Therapeutics Inc. | EWTX | Fox Jonathan C Director | 22,123 | $0 | 22,123 (Direct) | View |
2023-03-03 Option Award | 2023-03-07 5:59 pm | N/A 2033-03-03 | Edgewise Therapeutics Inc. | EWTX | Fox Jonathan C Director | 43,731 | $0 | 43,731 (Direct) | View |
2021-01-26 Equity Swap | 2021-01-28 7:50 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 380,467 | $0 | 0 (Direct) | View |
2020-12-28 Gift | 2021-01-28 7:50 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 500 | $0 | 0 (Direct) | View |
2021-01-26 Disposition | 2021-01-28 7:50 pm | N/A 2028-11-05 | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 70,000 | $0 | 0 (Direct) | View |
2020-06-29 Other | 2020-07-01 4:06 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 1,088 | $0 | 397,055 (Indirect) | View |
2020-06-01 Gift | 2020-06-05 4:06 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 2,040 | $0 | 394,879 (Indirect) | View |
2020-05-31 Option Award | 2020-06-05 4:06 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 444 | $41.57 | 394,879 (Direct) | View |
2020-02-04 Gift | 2020-02-19 06:05 am | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 1,632 | $0 | 421,475 (Indirect) | View |
2019-12-26 Gift | 2020-01-09 6:53 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 270 | $0 | 443,107 (Indirect) | View |
2019-11-26 Gift | 2019-12-05 7:31 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 1,000 | $0 | 443,377 (Indirect) | View |
2019-05-31 Option Award | 2019-07-17 4:05 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 1,769 | $12.01 | 504,377 (Direct) | View |
2018-11-30 Option Award | 2019-05-03 9:52 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 1,081 | $12.01 | 527,608 (Direct) | View |